Clinical Research Site

Charleston, South Carolina 29425

2 studies enrolling now · 10 studies all time

What they study most

Agitation in Patients With Dementia of the Alzheimer's Type, Cataplexy, Excessive Daytime Sleepiness, Excessive Sleepiness, Fibromyalgia, Migraine, Narcolepsy, Shift-work Disorder, Uveitis

Studies at this site

• Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN) — Recruiting now
• Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia — Enrolling by invitation
• A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy — Completed
• Initiating Early Control of Migraine Pain and Associated Symptoms — Completed
• Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE) — Completed
• A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE) — Completed
• Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitis — Stopped early
• Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT) — Completed
• Maximizing Outcomes in Treating Acute Migraine — Completed
• Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type — Completed